Literature DB >> 10666684

The "gene dosage effect" hypothesis versus the "amplified developmental instability" hypothesis in Down syndrome.

M A Pritchard1, I Kola.   

Abstract

Two hypotheses exist to explain the Down syndrome (DS) phenotype. The "gene dosage effect" hypothesis states that the phenotype is a direct result of the cumulative effect of the imbalance of the individual genes located on the triplicated chromosome or chromosome region. In a nut shell, the phenotype results directly from the overexpression of specific chromosome 21 genes. The "amplified developmental instability" hypothesis contends that most manifestations of DS may be interpreted as the results of a non-specific disturbance of chromosome balance, resulting in a disruption of homeostasis. This hypothesis was proposed in an attempt to explain the similarities between the phenotypes of different aneuploid states and the observation that all of the phenotypic traits in DS are also seen in the general population but at lower frequency, with less severity and usually only present as a single trait. Herein, we review recent data and present evidence to support the theory that the phenotypic traits of aneuploid syndromes, and DS in particular, result from the increased dosage of genes encoded on the triplicated chromosome.

Entities:  

Mesh:

Year:  1999        PMID: 10666684

Source DB:  PubMed          Journal:  J Neural Transm Suppl        ISSN: 0303-6995


  37 in total

1.  Gene expression from the aneuploid chromosome in a trisomy mouse model of down syndrome.

Authors:  Robert Lyle; Corinne Gehrig; Charlotte Neergaard-Henrichsen; Samuel Deutsch; Stylianos E Antonarakis
Journal:  Genome Res       Date:  2004-07       Impact factor: 9.043

2.  NF-kB1 gene expression in Down syndrome patients.

Authors:  Michele Salemi; Concetta Barone; Carmelo Romano; Francesco Scillato; Alda Ragalmuto; Salvatore Caniglia; Maria Grazia Salluzzo; Graziella Sciuto; Federico Ridolfo; Corrado Romano; Paolo Bosco
Journal:  Neurol Sci       Date:  2014-10-16       Impact factor: 3.307

3.  Expression profiling reveals fundamental biological differences in acute myeloid leukemia with isolated trisomy 8 and normal cytogenetics.

Authors:  K Virtaneva; F A Wright; S M Tanner; B Yuan; W J Lemon; M A Caligiuri; C D Bloomfield; A de La Chapelle ; R Krahe
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-30       Impact factor: 11.205

Review 4.  Down syndrome: the brain in trisomic mode.

Authors:  Mara Dierssen
Journal:  Nat Rev Neurosci       Date:  2012-12       Impact factor: 34.870

5.  Maternal Choline Supplementation Alters Basal Forebrain Cholinergic Neuron Gene Expression in the Ts65Dn Mouse Model of Down Syndrome.

Authors:  Christy M Kelley; Stephen D Ginsberg; Melissa J Alldred; Barbara J Strupp; Elliott J Mufson
Journal:  Dev Neurobiol       Date:  2019-06-09       Impact factor: 3.964

Review 6.  Neurological phenotypes for Down syndrome across the life span.

Authors:  Ira T Lott
Journal:  Prog Brain Res       Date:  2012       Impact factor: 2.453

7.  Segmental trisomy of chromosome 17: a mouse model of human aneuploidy syndromes.

Authors:  Tomás Vacík; Michael Ort; Sona Gregorová; Petr Strnad; Radek Blatny; Nathalie Conte; Allan Bradley; Jan Bures; Jirí Forejt
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-08       Impact factor: 11.205

8.  Domains of genome-wide gene expression dysregulation in Down's syndrome.

Authors:  Audrey Letourneau; Federico A Santoni; Ximena Bonilla; M Reza Sailani; David Gonzalez; Jop Kind; Claire Chevalier; Robert Thurman; Richard S Sandstrom; Youssef Hibaoui; Marco Garieri; Konstantin Popadin; Emilie Falconnet; Maryline Gagnebin; Corinne Gehrig; Anne Vannier; Michel Guipponi; Laurent Farinelli; Daniel Robyr; Eugenia Migliavacca; Christelle Borel; Samuel Deutsch; Anis Feki; John A Stamatoyannopoulos; Yann Herault; Bas van Steensel; Roderic Guigo; Stylianos E Antonarakis
Journal:  Nature       Date:  2014-04-17       Impact factor: 49.962

9.  The "Down syndrome critical region" is sufficient in the mouse model to confer behavioral, neurophysiological, and synaptic phenotypes characteristic of Down syndrome.

Authors:  Nadia P Belichenko; Pavel V Belichenko; Alexander M Kleschevnikov; Ahmad Salehi; Roger H Reeves; William C Mobley
Journal:  J Neurosci       Date:  2009-05-06       Impact factor: 6.167

10.  Behavioral Phenotyping for Down Syndrome in Mice.

Authors:  Randall J Roper; Charles R Goodlett; María Martínez de Lagrán; Mara Dierssen
Journal:  Curr Protoc Mouse Biol       Date:  2020-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.